NLSUI OPAC header image

Biotech patents : Enquivalency and exclusions under European and US patent law (Record no. 21448)

MARC details
000 -LEADER
fixed length control field 02103nam a2200217Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210929101959.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160316s2002 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789041188830
040 ## - CATALOGING SOURCE
Transcribing agency n
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 346.048600
Item number WES
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Westerlund Li
245 ## - TITLE STATEMENT
Title Biotech patents : Enquivalency and exclusions under European and US patent law
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. The Hague
Name of publisher, distributor, etc. Kluwer Law International
Date of publication, distribution, etc. 2002
300 ## - PHYSICAL DESCRIPTION
Extent 351p
365 ## - TRADE PRICE
Price amount Rs.7,188
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Summary: <br/>This book discusses patent legal issues regarding inventions in the field of biotechnology. The scope of a patent is of central concern, and since biotechnology is very different from other technologies, the requirements for disclosure and infringement are in focus. Eligibility issues are touched upon, although from more of an explanatory perspective, since the law is settled in this respect. The material for the analyses includes the European practices under the EPC, those of the United Kingdom, Germany, and the US. The mandated exclusions from patentability under the European patent laws of categories of plant and animal subject matter and certain biological processes are also analysed. Claim interpretation is the common theme. The challenge has been to present a comprehensive basis for grasping the substantive law for the field of biotechnology. The book examines thoroughly the differences between practices, and the consequences of those differences for the possibility of being granted a patent for an invention, and the infringement doctrines' effects for what might be called a patent's 'after-life', i.e. the scope of its protection. The principal message emerging in this book is the importance of relying on the policy arguments of uniformity and predictability in order to preserve a fair balance between an inventor and third parties, since in reality much of the controversy in this field turns on proper protection.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element 1.Patents - Biotechnology - European - U S A 2.Intellectual Property Rights - Patents - Biotechnology - U S A
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name
--
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type BOOKs
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
      Not For Loan . . CIPRA Section 30.05.2017 7188.00   346.0486 WES 19464 30.05.2017 30.05.2017 BOOKs